Literature DB >> 1165122

Effect of cyclophosphamide on the growth of Rickettsia sennetsu in experimentally infected mice.

N Tachibana, V Kobayashi.   

Abstract

The growth rate of Rickettsia sennetsu, the etiological agent of sennetsu rickettsiosis, a special type of infectious mononucleosis found in western Japan, is very low when the ordinary experimental methods used for other members of the rickettsiae are employed. Attempts have been made to increase its growth the rickettsiae are employed. Attempts have been made to increase its growth rate in cells and animals. By treating mice with cyclophosphamide, considerable enhancement of growth of the rickettsia was observed. In the drug-treated mice, infective titers expressed as mean lethal dose in the spleens reached 10(8,5) in animals treated by the intraperitoneal route three times at 5-day intervals with 0.33 mg/g (body weight). Infective titers in drug-treated mice were more than 100-fold above those of the infected non-drug-treated mice. In peritoneal cells of drug-treated mice rickettsial particles were observed in great abundance. The numbers of cells containing rickettsiae almost paralleled the infective titers of the spleens in each group in mice. Lymph nodes and spleens of the drug-treated mice diminished in size during infection.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1165122      PMCID: PMC415333          DOI: 10.1128/iai.12.3.625-629.1975

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  8 in total

1.  STUDIES ON INFECTIOUS MONONUCLEOSIS INDUCED IN THE MONKEY BY EXPERIMENTAL INFECTION WITH RICKETTSIA SENNETSU. I. CLINICAL OBSERVATIONS AND ETIOLOGICAL INVESTIGATIONS.

Authors:  A SHISHIDO; S HONJO; M SUGANUMA; S OHTAKI; M HIKITA; T FUJIWARA; M TAKASAKA
Journal:  Jpn J Med Sci Biol       Date:  1965-04

2.  INHIBITION OF HEMAGGLUTININ SYNTHESIS BY CYTOXAN.

Authors:  A W FRISCH; G H DAVIES
Journal:  Cancer Res       Date:  1965-06       Impact factor: 12.701

Review 3.  IMMUNOSUPPRESSIVE AGENTS.

Authors:  M C BERENBAUM
Journal:  Br Med Bull       Date:  1965-05       Impact factor: 4.291

4.  STUDIES ON INFECTIOUS MONONUCLEOSIS INDUCED IN THE MONKEY BY EXPERIMENTAL INFECTION WITH RICKETTSIA SENNETSU. II. PATHOLOGICAL FINDINGS.

Authors:  S OHTAKI; A SHISHIDO
Journal:  Jpn J Med Sci Biol       Date:  1965-04

5.  [Infectious mononucleosis or lymph node fever].

Authors:  T MISAO; Y KOBAYASHI; M SHIRAKAWA
Journal:  Sang       Date:  1957

6.  The influence of certain salts, amino acids, sugars, and proteins on the stability of rickettsiae.

Authors:  M R BOVARNICK; J C MILLER; J C SNYDER
Journal:  J Bacteriol       Date:  1950-04       Impact factor: 3.490

7.  Study on the effect of cyclophosphamide on experimental rickettsial infection.

Authors:  J Kazãr; R Brezina; V Mayer
Journal:  Acta Virol       Date:  1971-11       Impact factor: 1.162

8.  Studies on cyclophosphamide-induced tolerance to sheep erythrocytes.

Authors:  A C Aisenberg
Journal:  J Exp Med       Date:  1967-05-01       Impact factor: 14.307

  8 in total
  4 in total

1.  Modulation of delayed-type hypersensitivity and cellular immunity to microbial vaccines: effects of cyclophosphamide on the immune response to tularemia vaccine.

Authors:  M S Ascher; D Parker; J L Turk
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

2.  Susceptibility of mice treated with cyclophosphamide to lethal infection with Leptospira interrogans Serovar pomona.

Authors:  B Adler; S Faine
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

3.  Purification of complement-fixing antigens of Rickettsia sennetsu by ether treatment.

Authors:  N Tachibana; T Kusaba; I Matsumoto; Y Kobayashi
Journal:  Infect Immun       Date:  1976-04       Impact factor: 3.441

4.  Serodiagnosis of tsutsugamushi fever (scrub typhus) by the indirect immunoperoxidase technique.

Authors:  S Yamamoto; Y Minamishima
Journal:  J Clin Microbiol       Date:  1982-06       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.